Revised examination regulations for drug safety and efficacy launched from Dec. 22.

Published: 1999-12-27 17:02:00

Updated: 1999-12-27 17:02:00

As of Dec. 22 the bridge study system takes effect for evaluation of foreign clinical data which was recommended by ICH as one of scientifical and rational evaluation approaches for drug efficacy and safety of Korean patients in return of abolishing the current registration requirements of domest...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK